Finnish cleantech startup NPHarvest secures up to €1.2M from Business Finland to scale its nutrient recovery tech, converting waste-to-energy digestate into compliant fertilisers.

Heidelberg-based Exciva is developing first-in-class compounds to tackle neuropsychiatric conditions that resist current treatments, aiming to reshape brain health care.

EQT Life Sciences co-leads a €51M Series B in Exciva to advance a novel Alzheimer’s therapy targeting agitation and neuropsychiatric symptoms.

Former radio presenter behind gut-friendly toothpaste brand Gutology secures €2M to expand production, research and retail reach across Europe.

Hydrosat raises €51M to expand its thermal infrared satellite constellation and AI analytics, aiming to transform climate, agriculture and water risk monitoring.

Swiss biotech startup FluoSphera secures €1.23M to expand its female-led, animal-free, human-relevant drug discovery platform and accelerate safer, more predictive therapies.

Biotech startup Nuclera secures an extra $12M in Series C funding to accelerate protein production and compress drug discovery timelines.

Zurich-based Ahead Health secures €5.1M to expand its data-driven preventive healthcare platform and strengthen its footprint across European markets.

Cambridge-based Nuclera is reshaping drug discovery by giving labs rapid, benchtop access to functional proteins through its eProtein Discovery platform.